Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Dexamethasone for CINV Prevention in Cisplatin Chemotherapy
NCT04437017Phase 3Completed
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Feb 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Started Feb 2020; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04437017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04437017.